AI · 2h ago
Isomorphic Labs unveils drug design engine beyond AlphaFold
Isomorphic Labs, a subsidiary of Alphabet, has launched a new drug design engine that extends beyond its AlphaFold protein structure prediction system. The engine integrates generative AI and molecular simulations to accelerate drug discovery. It aims to reduce the time and cost of developing new therapeutics by enabling more precise molecular design.
Meridian48 take
While promising, the engine's real-world impact depends on whether it can consistently produce viable drug candidates, not just computational predictions.
Read the full reporting
The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold →
Hacker News
drug-discoveryalphafold